Xofluza (baloxavir marboxil)
Ended Awarded Last action
- Contract number
- 75A50324F80013
- Awardee
-
Genentech Usa, Inc. UEI SA85BMHCTXK5
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $21,999,907
Award facts
- Opportunity
-
- 75A50324Q00014 Solicitation number
- Contract value 100% obligated
- $21,999,906.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- South San Francisco, CA 94080, USA
Award details come from SAM.gov/FPDS.
About this award
This is a $21,999,906.94 Firm Fixed Price Delivery Order contract awarded to Genentech USA, Inc. by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency within the U.S. Department of Health and Human Services. The contract is for the antiviral drug XOFLUZA (baloxavir marboxil) and has a period of performance through September 29, 2025. Genentech is a foreign-owned, for-profit manufacturer of pharmaceuticals and biologics that holds several broad contract vehicles with federal agencies, including a $4.9 billion Federal Supply Schedule with the Department of Veterans Affairs and a $27.9 million Indefinite Delivery contract with the Defense Logistics Agency. This award is not associated with any set-aside designation.
Quick answers
Who was awarded contract 75A50324F80013?
75A50324F80013 was awarded to Genentech Usa, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 30, 2024.
How much is contract 75A50324F80013 worth?
The government has obligated $21,999,907 on 75A50324F80013.
Is contract 75A50324F80013 an order under another contract?
Yes. 75A50324F80013 is a delivery order under 36F79723D0219, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 75A50324F80013 competed?
The extent of competition for 75A50324F80013 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award